← Eichor
Condition: Pediatric Migraine Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pediatric Migraine

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Partici
Phase 3 · 64 location(s) · AbbVie · NCT06810505Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · 90 location(s) · Pfizer · NCT05156398A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine
NA · 1 location(s) · Children's Mercy Hospital Kansas City · NCT07454798MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat
NA · 1 location(s) · Medical University Innsbruck · NCT07419607Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Phase N/A · 3 location(s) · Danone Nutricia SpA Società Benefit · NCT06309251Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine
NA · 1 location(s) · Muhammad Aamir Latif · NCT07354126A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Phase 1 · 13 location(s) · Pfizer · NCT06995729Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Phase 3 · 125 location(s) · Pfizer · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Phase 3 · 246 location(s) · Pfizer · NCT04649242Assessment of the Effectiveness of Virtual Reality as a Learning Tool for Relaxation Techniques in Reducing Pediatric Mi
NA · 1 location(s) · University of Liege · NCT06921109A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · 65 location(s) · H. Lundbeck A/S · NCT05897320A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants
Phase 3 · 98 location(s) · AbbVie · NCT05711394Responding With Evidence and Access for Childhood Headaches
NA · 15 location(s) · Children's Hospital Medical Center, Cincinnati · NCT05889624Mind Body Balance for Pediatric Migraine
NA · 2 location(s) · Children's Hospital Medical Center, Cincinnati · NCT04715685
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.